Ipsen shines at ESG Life Sciences Summit Europe 2024 

The ESG Life Sciences Summit Europe, held in June brought together industry leaders to discuss how the life sciences sector can drive meaningful change through ESG initiatives. 

Gareth Collins, VP of Sustainability & EHS, presented our proactive approach to meeting the Corporate Sustainability Reporting Directive (CSRD) requirements and the importance of integrating sustainability reporting into business transformation strategy. 

Gareth also participated in a panel discussion on promoting sustainable practices in the biopharmaceutical industry. The panel explored how to measure environmental impact and identify key decarbonization strategies. It also discussed collective actions to engage employees in sustainability efforts and the importance of transparency through data-sharing across organizations. 

The summit provided a platform to showcase Generation Ipsen, our transformative sustainability strategy launched in 2022. Generation Ipsen is anchored by four key pillars: Environment, Patients, People, and Governance, reflecting Ipsen’s commitment to positive change. Our strategy includes significant achievements, such as reducing greenhouse gas emissions and promoting gender balance in leadership, underscoring our progress towards our 2023 sustainability targets. 

Our journey towards sustainability goes beyond regulatory compliance; we aim to lead the industry with innovative ESG approaches, fostering continuous improvement, and making a positive impact.